Product was DataMeds AI’s largest product and service line in fiscal 2025, bringing in $21.87M of $23.34M (94%).
| Product and Service | FY 2024 | FY 2025 |
|---|---|---|
| Product | $17.67M | $21.87M |
| Pharmacy Retail Sales | $352.36K | $865.70K |
| Third Party Logistics Services | $107.00K | $603.42K |
| Total | $18.13M | $23.34M |
DataMeds AI brought in $23.34M from its three product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 28.7% from $18.13M in fiscal 2024. Product was the largest at $21.87M (93.7%), ahead of Pharmacy Retail Sales at $865.70K (3.7%) and Third Party Logistics Services at $603.42K (2.6%).
Compared with fiscal 2024, Third Party Logistics Services grew fastest, up 463.9% to $603.42K. Every line above 2% of revenue grew.
DataMeds AI (MEDS) reports its revenue by product and service. In fiscal 2025, Product was its largest product and service line, bringing in $21.87M (93.7% of the total), followed by Pharmacy Retail Sales at $865.70K (3.7%).
Product was DataMeds AI's largest product and service line in fiscal 2025, bringing in $21.87M, or 93.7% of the $23.34M total across its three product and service lines.
Among DataMeds AI's product and service lines that make up at least 2% of revenue, Third Party Logistics Services grew fastest in fiscal 2025, up 463.9% from $107.00K to $603.42K.
Every figure comes from DataMeds AI's annual financial filings, as reported. Each line keeps the name DataMeds AI gives it, and years follow its fiscal calendar.
DataMeds AI's revenue by product and service goes back to fiscal 2024, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.